-
-
-
-
-
-
-
Blueprint Medicines to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025
-
-
-
-
-
-
-
Blueprint Medicines (BPMC) Tops Q3 EPS by 7c ; Offers Guidance
-
-
-
-
-
-
-
Blueprint Medicines Reports Strong First Quarter 2024 Results and Raises AYVAKIT®/AYVAKYT® (avapritinib) Full Year Revenue Guidance
-
-
-
-
-
-
-
Blueprint Medicines Highlights 2024 Corporate Strategy and Business Priorities at 42nd Annual J.P. Morgan Healthcare Conference
-
-
-
-
-
-
-
Blueprint Medicines to Report Second Quarter 2023 Financial Results on Wednesday, August 2, 2023
-
-
-
-
-
-
-
Blueprint Medicines to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 16, 2023
-
-
-
-
-
-
-
CANCER Publishes Study Demonstrating Substantial Disease Burden for Patients with Systemic Mastocytosis
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

